Mirae Asset Global Investments Co., Ltd. Regenxbio Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Regenxbio Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,788 shares of RGNX stock, worth $20,007. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,788
Previous 1,471
21.55%
Holding current value
$20,007
Previous $17,000
5.88%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding RGNX
# of Institutions
197Shares Held
43.2MCall Options Held
58.9KPut Options Held
58.4K-
Black Rock Inc. New York, NY8.61MShares$96.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$57.2 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.57MShares$51.1 Million3.49% of portfolio
-
State Street Corp Boston, MA2.87MShares$32.2 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.48MShares$27.7 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $484M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...